Cellular Biomedicine Group (CBMG) Reports Q2 Loss of $0.52/Share
Tweet
Share
E-mailGet Alerts CBMG Hot Sheet
Join SI Premium – FREE
Cellular Biomedicine Group (NASDAQ: CBMG) reported Q2 EPS of ($0.52), versus ($0.44) reported last year. Revenue for the quarter came in at $71.6 thousand, versus $656.96 thousand reported last year.
For earnings history and earnings-related data on Cellular Biomedicine Group (CBMG) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- L3Harris CEO steps down amid conduct review, shares drop
- Paramount Global (PARA) Tops Q2 EPS by 480c
- Huazhu Group Limited (HTHT) Tops Q2 EPS by 37c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
